Home/Aquinnah Pharmaceuticals/Bob Carpenter

BC

Bob Carpenter

Board Member

Aquinnah Pharmaceuticals

Therapeutic Areas

Alzheimer's Disease Amyotrophic Lateral Sclerosis (ALS)Neurodegenerative Diseases

Aquinnah Pharmaceuticals Pipeline

Drug	Indication	Phase
Undisclosed Small Molecule	Alzheimer's Disease	Preclinical

Leadership Team at Aquinnah Pharmaceuticals

Dr. Glenn Larsen

Co-founder, President and CEO

Dr. Ben Wolozin

Co-founder and Chief Scientific Officer

View full Aquinnah Pharmaceuticals profile